Dr. Anne Marie Morse discusses the link between cancer and sleep and circadian science. Dr. Morse and co-host Matthew Allard are joined by Mollie Eastman to discuss cutting-edge research in sleep medicine. Dr. Anne Marie Morse discusses the challenges of treating children and adolescents with narcolepsy. Dr. Anne Marie Morse details how having a sleep disorder can impact personal and professional relationships. Dr. Anne Marie Morse, who was in attendance at SLEEP 2024, recapped the most notable research from the event. Dr. Anne Marie Morse and co-host continue their discussion with retired NFL player Josh Andrews on his narcolepsy diagnosis. The use of tirzepatide in patients with obstructive sleep apnea and obesity improves both OSA severity and metabolic issues. Joel Latham, head of Incannex Healthcare, discusses IHL-42X, a proprietary treatment combination for patients with OSA. Gary Garcia-Molina details the connection between obstructive sleep apnea and CVD and explains how smart beds can help. Dr. Anne Marie Morse and co-host Matthew Allard speak with ex-NFL player Josh Andrews about how narcolepsy affects his life. Depression is common in individuals with obstructive sleep apnea, and this is especially true in women. Obstructive sleep apnea and asthma share common biological pathways. A study identified attributes driving treatment preference in caregivers of pediatric patients with narcolepsy. Dr. Morse, a premier thought leader in sleep health, previews the upcoming SLEEP 2024 meeting. H1N1 and influenza B viruses may trigger narcolepsy with cataplexy. People with poor sleep and high genetic risk have a significantly higher risk of developing digestive diseases. Midpoint of sleep is associated with multiple measures of sleep quality and could be a biomarker for AD risk. Sleep alterations occur with considerable frequency in chronic stroke patients and can lead to worse outcomes. Many cardio-oncology patients at increased risk for congestive heart failure from cancer therapy have OSA. Excessive daytime sleepiness was linked to a higher risk of premature all-cause death in female patients with OSA.